"The NTAGI's Standing Technical Subcommittee that held a meeting on Friday has recommended taking Sputnik light as a precaution dose, which has the same component of Sputnik V first dose," the sources said, as quoted by the news agency.
In February, Indian Drugs Controller General allowed health facilities to use the Sputnik Light single-component vaccine. In March, Hetero Biopharma became the first Indian pharmaceutical company that received permission to produce and sell the single-component Sputnik Light vaccine.
The Sputnik Light vaccine is the first component of Russia's Sputnik V vaccine. Advantages of using Sputnik Light include a simple vaccination process, the opportunity to increase the effectiveness and duration of action of other vaccines.